Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Some clinicians prefer to reduce the dose stepwise (for example, moving from a higher to lower maintenance dose before stopping completely) to allow for metabolic adjustment and medication changes
About 70% of the time, the disease occurs on the dorsal (top) surface of the penis
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
A patient can verify whether Emerge's pharmacy partner is on that list by searching the FDA's registered outsourcing facilities database directly 9
* Real People
US$ 24.27
US$ 20.45
US$ 29.86
US$ 29.50
US$ 25.04
US$ 25.88
US$ 20.23
US$ 29.16
US$ 29.66
US$ 24.36
US$ 28.61
US$ 23.37
US$ 22.66
